Tejnaksh Healthcare (BOM:539428) 5-Year Yield-on-Cost %: 0.00 (As of Sep. 09, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:539428 Tejnaksh Healthcare Ltd BOM:539428
65 GF Score
Price ₹13.70
GF Value ₹19.62
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Tejnaksh Healthcare 5-Year Yield-on-Cost %?

Tejnaksh Healthcare BOM:539428 -0.51% 65 5-Year Yield-on-Cost % is 0.00 as of Sep. 09, 2026. GuruFocus rates BOM:539428 with a GF Score™ of 65/100 and a GF Value™ of ₹19.62 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 280 Healthcare Providers & Services companies, Tejnaksh Healthcare ranks worse than 357142.5% on this metric.

Tejnaksh Healthcare's yield on cost for the quarter that ended in Jun. 2026 was 0.00.


The historical rank and industry rank for Tejnaksh Healthcare's 5-Year Yield-on-Cost % or its related term are showing as below:



BOM:539428's 5-Year Yield-on-Cost % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.915
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Tejnaksh Healthcare  (BOM:539428) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Tejnaksh Healthcare 5-Year Yield-on-Cost % Related Terms


BOM:539428 vs HCA, THC, EHC: 5-Year Yield-on-Cost % Comparison

For the Medical Care Facilities subindustry, Tejnaksh Healthcare's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tejnaksh Healthcare 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Tejnaksh Healthcare's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Tejnaksh Healthcare's 5-Year Yield-on-Cost % falls into.


BOM:539428
65GF Score
Tejnaksh Healthcare Ltd BOM:539428
5-Year Yield-on-Cost % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tejnaksh Healthcare 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Tejnaksh Healthcare is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 0.00 mean?
Tejnaksh Healthcare (BOM:539428) has a 5-Year Yield-on-Cost % of 0.00 as of Sep. 09, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Tejnaksh Healthcare and its competitors. According to the industry distribution chart, Tejnaksh Healthcare ranks #999999 out of 280 companies in the Healthcare Providers & Services industry.
Is Tejnaksh Healthcare's 5-Year Yield-on-Cost % too high?
Tejnaksh Healthcare's current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, Tejnaksh Healthcare ranks #999999 out of 280 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Tejnaksh Healthcare has a GF Score™ of 65/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Tejnaksh Healthcare's 5-Year Yield-on-Cost % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Tejnaksh Healthcare ranks #999999 out of 280 companies for 5-Year Yield-on-Cost %. This places Tejnaksh Healthcare in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.92. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.92, based on 280 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Tejnaksh Healthcare and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tejnaksh Healthcare's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tejnaksh Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Tejnaksh Healthcare (BOM:539428) is currently considered Possible Value Trap. The stock's GF Value™ is ₹19.62, compared to a current price of ₹13.70 — trading 30.2% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. Tejnaksh Healthcare's overall GF Score™ is 65/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Tejnaksh Healthcare (BOM:539428), the current 5-Year Yield-on-Cost % is 0.00 as of Sep. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tejnaksh Healthcare (BOM:539428) Overvalued in 2026?

Based on GuruFocus' analysis, Tejnaksh Healthcare stock appears to be undervalued. The current stock price of ₹13.70 is trading 30.2% below its estimated GF Value™ of ₹19.62. GuruFocus considers Tejnaksh Healthcare to be Possible Value Trap.

Key valuation signals for BOM:539428:

  • 5-Year Yield-on-Cost %: 0.00
  • GF Value™: ₹19.62 vs. price of ₹13.70 (30.2% below fair value)
  • GF Score™: 65/100 with 4 warning signs

No single metric tells the full story. See the BOM:539428 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Tejnaksh Healthcare Business Description

Address Institute of Urology, Sakri Road, Dhule, MH, IND, 424 001
Tejnaksh Healthcare Ltd is engaged in the provision of hospital and healthcare services. Geographically, it operates only in India. The company has a single operating segment, namely health care services. The company domains include Urology Hospitals; Nephrology Hospitals; Dental Clinics; Healthcare Equipment, Research and Development and others. It generates maximum revenue from fees charged under contract for inpatient and outpatient hospital services and also includes sale of medical and non-medical items. Hospital services include charges for accommodation, medical professional services, pathology and pharmaceutical goods used in treatments given to patient.
65GF Score

Get the complete analysis for BOM:539428

5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹13.70
Price
₹19.62
GF Value